Pathstone Holdings, LLC Milestone Pharmaceuticals Inc. Transaction History
Pathstone Holdings, LLC
- $25.6 Billion
- Q3 2025
A detailed history of Pathstone Holdings, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 1,000,000 shares of MIST stock, worth $2.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$2.06 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
61Shares Held
22.6MCall Options Held
160KPut Options Held
34.8K-
Adage Capital Partners Gp, L.L.C. Boston, MA6.98MShares$14.4 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA5.12MShares$10.6 Million10.26% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$10.2 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.84 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.16 Million0.07% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $61.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...